| Home | E-Submission | Sitemap | Editorial Office
top_img
   
REVIEW
Life-sustaining treatment and palliative care in patients with liver cirrhosis - legal, ethical, and practical issues
With the enactment of the ‘Act on Decisions on Life-Sustaining Treatment for Patients in Hospice and Palliative Care or at the End of Life’ (Act No. 14013) in Korea, there is growing concern about the practicality of this law. In this review, we discuss definitions, ethics, a...
ORIGINAL ARTICLE
A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function
Background/Aims: Metronomic chemotherapy (MET) is frequently administered in comparatively low doses as a continuous chemotherapeutic agent. The aim of this study was to evaluate the feasibility and overall survival (OS) of MET compared to sorafenib for advanced hepatocellular c...
ORIGINAL ARTICLE
Meta-analysis of the correlation between the rs17401966 polymorphism in kinesin family member 1B and susceptibility to hepatitis B virus related hepatocellular carcinoma
Background/Aims: The association between the kinesin family member 1B (KIF1B) gene polymorphism and the risk of hepatitis B virus-related hepatocellular carcinoma (HCC) has been investigated in many peer-reviewed studies. However, scholars have failed to replicate these results ...
Current Issue
Volume 23(2); Jun 2017
Volume 23(1); March 2017
Volume 22(4); December 2016
Volume 22(3); September 2016
Volume 22(2); June 2016
RSS feed
Reviews
103 NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs
Stephen Caldwell
Clin Mol Hepatol.2017;23(2):103-108.   Published online May 10, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0103
                              
109 Radioembolization for the treatment of hepatocellular carcinoma
Hyo-Cheol Kim
Clin Mol Hepatol.2017;23(2):109-114.   Published online May 10, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0004
                              
115 Life-sustaining treatment and palliative care in patients with liver cirrhosis - legal, ethical, and practical issues
Dong Joon Kim, Moon Seok Choi
Clin Mol Hepatol.2017;23(2):115-122.   Published online May 2, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0018
                              
Editorials
123 Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
Do Young Kim
Clin Mol Hepatol.2017;23(2):123-124.   Published online June 23, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0107
      
125 Is alanine aminotransferase flare-up in nucleos(t)ide analogue treatment of chronic hepatitis B a promising, rather than a devastating, sign?
Nae-Yun Heo
Clin Mol Hepatol.2017;23(2):125-127.   Published online June 23, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0106
      
Original Articles
128 A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function
Hyun Yang, Hyun Young Woo, Soon Kyu Lee, Ji Won Han, Bohyun Jang, Hee Chul Nam, Hae Lim Lee, Sung Won Lee, Do Seon Song, Myeong Jun Song, Jung Suk Oh, Ho Jong Chun, Jeong Won Jang, Angelo Lozada, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Clin Mol Hepatol.2017;23(2):128-137.   Published online May 10, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0071
                              Supplementary      
138 Meta-analysis of the correlation between the rs17401966 polymorphism in kinesin family member 1B and susceptibility to hepatitis B virus related hepatocellular carcinoma
Mingkuan Su, Jianfeng Guo, Jiancheng Huang
Clin Mol Hepatol.2017;23(2):138-146.   Published online April 21, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0083
                              
147 Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis
Oidov Baatarkhuu, Hye Won Lee, Jacob George, Dashchirev Munkh-Orshikh, Baasankhuu Enkhtuvshin, Sosorbaram Ariunaa, Mohammed Eslam, Sang Hoon Ahn, Kwang-Hyub Han, Do Young Kim
Clin Mol Hepatol.2017;23(2):147-153.   Published online May 2, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0055
                              
154 Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B
Hee Yeon Seo, Han Ah Lee, Soon Young Ko, Joon Ho Wang, Jeong Han Kim, Won Hyeok Choe, So Young Kwon
Clin Mol Hepatol.2017;23(2):154-159.   Published online May 8, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0067
                              
160 Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion
Jihyun An, Kwang Sun Lee, Kang Mo Kim, Do Hyun Park, Sang Soo Lee, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee
Clin Mol Hepatol.2017;23(2):160-169.   Published online May 16, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0088
                              
170 Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B
Won Sohn, Ju-Yeon Cho, Ji Hoon Kim, Jung Il Lee, Hyung Joon Kim, Min-Ah Woo, Sin-Ho Jung, Yong-Han Paik
Clin Mol Hepatol.2017;23(2):170-178.   Published online May 16, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0086
                              Supplementary      
Case Reports
179 A case of ruptured hepatic angiomyolipoma in a young male
Sun Hwa Kim, Tae Wook Kang, Kyunghee Lim, Hyun Sung Joh, Jiseok Kang, Dong Hyun Sinn
Clin Mol Hepatol.2017;23(2):179-183.   Published online April 28, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0027
                              
184 Development of autoimmune hepatitis in a psoriasis patient without immunosuppressive therapy
Wonyong Jo, Young-Sun Suh, Sang-Il Lee, Yun-Hong Cheon, Jeongmin Hong, Sang Su Lee, Ji Eun Kim, Gyung Hyuck Ko, Hyun-Ok Kim
Clin Mol Hepatol.2017;23(2):184-187.   Published online May 8, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0035
                              
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.